Literature DB >> 28750321

Modeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice.

Kimberly Schmitt1, Dipu Mohan Kumar1, James Curlin1, Leila Remling-Mulder1, Mark Stenglein1, Shelby O'Connor2, Preston Marx3, Ramesh Akkina4.   

Abstract

HIV-2 is thought to have originated from an SIV progenitor native to sooty mangabeys. To model the initial human transmission and understand the sequential viral evolution, humanized mice were infected with SIVsm and serially passaged for five generations. Productive infection was seen by week 3 during the initial challenge followed by chronic viremia and gradual CD4+ T cell decline. Viral loads increased by the 5th generation resulting in more rapid CD4+ T cell decline. Genetic analysis revealed several amino acid substitutions that were nonsynonymous and fixed in multiple hu-mice across each of the 5 generations in the nef, env and rev regions. The highest rate of substitution occurred in the nef and env regions and most were observed within the first two generations. These data demonstrated the utility of hu-mice in modeling the SIVsm transmission to the human and to evaluate its potential sequential evolution into a human pathogen of HIV-2 lineage.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cross-species viral transmission; Modeling SIV evolution into HIV in humanized mice; Origin of human pathogens in NHP; SIV genetic changes towards HIV-2; SIV pathogenesis in humanized mice; SIVsm evolution into HIV-2 lineage; Viral adaptive changes and genetic evolution

Mesh:

Substances:

Year:  2017        PMID: 28750321      PMCID: PMC5906053          DOI: 10.1016/j.virol.2017.07.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  79 in total

1.  Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.

Authors:  J Bai; S Gorantla; N Banda; L Cagnon; J Rossi; R Akkina
Journal:  Mol Ther       Date:  2000-03       Impact factor: 11.454

2.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

3.  Serial human passage of simian immunodeficiency virus by unsterile injections and the emergence of epidemic human immunodeficiency virus in Africa.

Authors:  P A Marx; P G Alcabes; E Drucker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-06-29       Impact factor: 6.237

Review 4.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

5.  Human immunodeficiency viruses: SIV infection in wild gorillas.

Authors:  Fran Van Heuverswyn; Yingying Li; Cecile Neel; Elizabeth Bailes; Brandon F Keele; Weimin Liu; Severin Loul; Christelle Butel; Florian Liegeois; Yanga Bienvenue; Eitel Mpoudi Ngolle; Paul M Sharp; George M Shaw; Eric Delaporte; Beatrice H Hahn; Martine Peeters
Journal:  Nature       Date:  2006-11-09       Impact factor: 49.962

6.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

7.  Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Authors:  A Mörner; A Björndal; J Albert; V N Kewalramani; D R Littman; R Inoue; R Thorstensson; E M Fenyö; E Björling
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year.

Authors:  Bradford K Berges; Sarah R Akkina; Leila Remling; Ramesh Akkina
Journal:  Virology       Date:  2009-11-18       Impact factor: 3.616

9.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

10.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  11 in total

1.  SIVcpz cross-species transmission and viral evolution toward HIV-1 in a humanized mouse model.

Authors:  James Curlin; Kimberly Schmitt; Leila Remling-Mulder; Ryan Moriarty; Mark Stenglein; Shelby O'Connor; Preston Marx; Ramesh Akkina
Journal:  J Med Primatol       Date:  2019-10-01       Impact factor: 0.667

2.  Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.

Authors:  Elena Heusinger; Katja Deppe; Paola Sette; Christian Krapp; Dorota Kmiec; Silvia F Kluge; Preston A Marx; Cristian Apetrei; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

3.  Mimicking SIV chimpanzee viral evolution toward HIV-1 during cross-species transmission.

Authors:  Kimberly Schmitt; James Curlin; Leila Remling-Mulder; Ryan Moriarty; Kelly Goff; Shelby O'Connor; Mark Stenglein; Preston Marx; Ramesh Akkina
Journal:  J Med Primatol       Date:  2020-08-17       Impact factor: 0.667

4.  SIV progenitor evolution toward HIV: A humanized mouse surrogate model for SIVsm adaptation toward HIV-2.

Authors:  Kimberly Schmitt; James Curlin; Dipu Mohan Kumar; Leila Remling-Mulder; Stephanie Feely; Mark Stenglein; Shelby O'Connor; Preston Marx; Ramesh Akkina
Journal:  J Med Primatol       Date:  2018-10       Impact factor: 0.667

5.  Evolution of SIVsm in humanized mice towards HIV-2.

Authors:  James Curlin; Kimberly Schmitt; Leila Remling-Mulder; Ryan Moriarty; Kelly Goff; Shelby O'Connor; Mark Stenglein; Preston Marx; Ramesh Akkina
Journal:  J Med Primatol       Date:  2020-08-10       Impact factor: 0.667

6.  2017 international meeting of the Global Virus Network.

Authors:  Mike Catton; Glenda Gray; Diane Griffin; Hideki Hasegawa; Stephen J Kent; Jason Mackenzie; Edward McSweegan; Natalia Mercer; Linfa Wang
Journal:  Antiviral Res       Date:  2018-02-05       Impact factor: 5.970

Review 7.  Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses.

Authors:  Amy Gillgrass; Jocelyn M Wessels; Jack X Yang; Charu Kaushic
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

8.  A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model.

Authors:  Izabela K Ragan; Lindsay M Hartson; Taru S Dutt; Andres Obregon-Henao; Rachel M Maison; Paul Gordy; Amy Fox; Burton R Karger; Shaun T Cross; Marylee L Kapuscinski; Sarah K Cooper; Brendan K Podell; Mark D Stenglein; Richard A Bowen; Marcela Henao-Tamayo; Raymond P Goodrich
Journal:  Vaccines (Basel)       Date:  2021-04-01

9.  Evolution of SIVmac239 following serial passaging in humanized mice.

Authors:  James Z Curlin; Kimberly Schmitt; Leila Remling-Mulder; Jared Morrison; John J Baczenas; Corina Valencia Tibbits; Kelly Goff; Shelby O'Connor; Mark Stenglein; Preston Marx; Ramesh Akkina
Journal:  J Med Primatol       Date:  2022-08-28       Impact factor: 0.821

10.  Cross-Species Transmission and Evolution of SIV Chimpanzee Progenitor Viruses Toward HIV-1 in Humanized Mice.

Authors:  Kimberly Schmitt; James Curlin; Leila Remling-Mulder; Ryan Moriarty; Kelly Goff; Shelby O'Connor; Mark Stenglein; Preston Marx; Ramesh Akkina
Journal:  Front Microbiol       Date:  2020-08-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.